FDA recall Z-1350-2018

Neuropro Spinal Jaxx · Class II · device

Product

Spinal Jaxx Interbody Fusion Device, Model: 100001-511, Size: 9 H x 10 W x 25 L Product Usage: The Spinal Jaxx interbody fusion device is indicated for spinal fusion for patients with degenerative disc disease (DDD) at one or two contiguous levels of the lumbosacral spine (L2-S1). DDD is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies. Patients may also have up to Grade 1 spondylolisthesis or retrolisthesis at the involved level(s). The indicated patient population is skeletally mature patients who have had six (6) months of non-operative treatment. The Spinal Jaxx interbody fusion device must be used with autogenous bone graft material and with supplemental fixation.

Reason for recall

The implant size is incorrectly etched on the implant. The size listed on the box is correct.

Distribution

The devices were distributed in California.

Key facts

Status
Terminated
Initiation date
2018-01-18
Report date
2018-04-18
Termination date
2018-07-13
Voluntary/Mandated
Voluntary: Firm initiated
Location
Burke, VA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1350-2018